 Untoward effects will be measured and recorded at each visit employing the following measures: 1 Dosage Record and Treatment Emergent Symptom Scale DOTES; 2 Treatment Emergent Symptoms Scale TESS; 3 Abnormal Involuntary Movement Scale AIMS all from Psychopharmacology Bulletin, 1985; and 4 the Neurologic Rating Scale Simpson and Angus, 1970. The DOTES and TESS measure a wide range of possible untoward effects. The AIMS measures dyskinesias. The Neurologic Rating Scale measures other forms of extrapyramidal effects that can occur with neuroleptics such as dystonias, parkinsonian effects, and akathisia. 